{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:32:25Z","timestamp":1794486745338,"version":"4.9.1"},"reference-count":31,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"BeOne Medicines Ltd."},{"name":"BeOne Medicines, Ltd."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2025.2609514","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:23:08Z","timestamp":1768832588000},"page":"180-192","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Prolonged progression-free survival with zanubrutinib in relapsed\/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression"],"prefix":"10.1080","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-6562","authenticated-orcid":false,"given":"Mazyar","family":"Shadman","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Research Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9592-5548","authenticated-orcid":false,"given":"Walter","family":"Bouwmeester","sequence":"additional","affiliation":[{"name":"Precision AQ, HEOR","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Mohseninejad","sequence":"additional","affiliation":[{"name":"BeOne Medicines","place":["Schiphol, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-6780","authenticated-orcid":false,"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-401X","authenticated-orcid":false,"given":"Milica","family":"Jevdjevic","sequence":"additional","affiliation":[{"name":"Precision AQ, HEOR","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Yang","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd","place":["San Mateo, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys","family":"Williams","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd","place":["San Mateo, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen P.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Precision AQ, HEOR","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820910"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0779-z"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.03355"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/rssa.12579"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.04.002"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01044-4"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.05.004"},{"key":"e_1_3_6_12_1","doi-asserted-by":"crossref","unstructured":"Phillippo DM Dias S Welton NJ et al. Multilevel network meta-regression for general likelihoods: synthesis of individual and aggregate data with applications to survival analysis. arXiv preprint arXiv:240112640 2024.","DOI":"10.1093\/jrsssa\/qnaf169"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X221117162"},{"key":"e_1_3_6_14_1","unstructured":"NICE. Quizartinib for induction consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia. NICE Technology appraisal guidance. 2024. https:\/\/www.nice.org.uk\/guidance\/TA1013"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01460-1"},{"issue":"12","key":"e_1_3_6_16_1","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/bloodadvances.2024014523","article-title":"Comparative efficacy of bruton tyrosine kinase inhibitors in the treatment of relapsed\/refractory chronic lymphocytic leukemia: a network meta-analysis","volume":"9","author":"Shadman M","year":"2025","unstructured":"Shadman M, Brown JR, Mohseninejad L, et al. Comparative efficacy of bruton tyrosine kinase inhibitors in the treatment of relapsed\/refractory chronic lymphocytic leukemia: a network meta-analysis. Blood Adv. 2025;9(12):2863\u20132870.","journal-title":"Blood Adv"},{"key":"e_1_3_6_17_1","unstructured":"Phillippo DM Ades AE Dias S et al. NICE DSU Technical Support Document 18: methods for population-adjusted indirect comparisons in submission to NICE. 2016."},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x17725740"},{"key":"e_1_3_6_19_1","doi-asserted-by":"crossref","first-page":"175883592513405","DOI":"10.1177\/17588359251340554","article-title":"Efficacy of zanubrutinib versus acalabrutinib in the treatment of relapsed or refractory chronic lymphocytic leukemia (R\/R CLL): a Matching-Adjusted Indirect Comparison (MAIC)","volume":"17","author":"Shadman M","year":"2025","unstructured":"Shadman M, Brown JR, Williams R, et al. Efficacy of zanubrutinib versus acalabrutinib in the treatment of relapsed or refractory chronic lymphocytic leukemia (R\/R CLL): a Matching-Adjusted Indirect Comparison (MAIC). Ther Adv Med Oncol. 2025;17:17588359251340554.","journal-title":"Ther Adv Med Oncol"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11222-016-9696-4"},{"key":"e_1_3_6_21_1","unstructured":"Dias S Welton NJ Sutton AJ et al. NICE decision support unit technical support documents. NICE DSU Technical Support Document 2: a Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. National Institute for Health and Care Excellence (NICE). Copyright \u00a9 2014 National Institute for Health and Clinical Excellence unless otherwise stated. All rights reserved; 2014."},{"key":"e_1_3_6_22_1","unstructured":"Phillippo D. multinma: bayesian Network Meta-Analysis of Individual and Aggregate Data. R package version 0.5.1; 2023. https:\/\/dmphillippo.github.io\/multinma\/."},{"key":"e_1_3_6_23_1","unstructured":"Stan Development Team. Stan modeling language users guide and reference manual 2.34. https:\/\/mc-stan.org."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1177011136"},{"key":"e_1_3_6_25_1","doi-asserted-by":"crossref","DOI":"10.1201\/b16018","volume-title":"Bayesian data analysis","author":"Gelman A.","year":"2013","unstructured":"Gelman A. Bayesian data analysis. 3rd ed. Boca Raton: Texts in Statistical Science; 2013.","edition":"3"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012221"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1978288"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00902-x"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011641"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241263710"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.04.018"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000969432.47546.cf"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2609514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:23:09Z","timestamp":1768832589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2609514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2609514"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2609514","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}